Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-07T07:23:44.321Z Has data issue: false hasContentIssue false

Advancing health equity through action in antimicrobial stewardship and healthcare epidemiology

Published online by Cambridge University Press:  14 February 2024

Jasmine R. Marcelin*
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska
Lauri A. Hicks
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia
Christopher D. Evans
Affiliation:
Healthcare-Associated Infections and Antimicrobial Resistance Program, Tennessee Department of Health, Nashville, Tennessee
Zanthia Wiley
Affiliation:
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Ibukunoluwa C. Kalu
Affiliation:
Division of Pediatric Infectious Disease, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina
Jacinda C. Abdul-Mutakabbir
Affiliation:
Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California Division of the Black Diaspora and African American Studies, University of California San Diego, La Jolla, California
*
Corresponding author: Jasmine R. Marcelin; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Type
Commentary
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Health equity is the state in which everyone has a fair and just opportunity to attain their highest level of health. 1 Health inequities occur when unfair processes in the distribution of resources affecting health disproportionately prevent the attainment of that highest level of health in specific populations. Reference Braveman and Gruskin2,Reference People3 Health inequities are pervasive and lead to differential patient outcomes for a variety of disease states, ranging from chronic diseases like Type 2 diabetes mellitus and hypertension to infections like coronavirus disease-2019 (COVID-19). 1 Infection risk in health care and quality of antibiotic use vary by patient population. Reference Brown, Henderson, Ruegsegger, Moody and van Duin4Reference Kim, Kabbani and Dube17 Thus, opportunities exist for education and awareness about health equity and how it applies to infectious diseases, healthcare epidemiology, and antimicrobial stewardship. To underscore the importance of preparing the healthcare workforce to understand, recognize, and respond to health inequities, Uehling et al Reference Uehling, Hall-Clifford, Kinnard and Wimberly18 asked >200 hospital employees to describe their understanding of health equity as a concept, and perceptions of equity initiatives implemented in their hospital. In the results of their survey, published in 2023, <25% of respondents could correctly define either health equity or equity at a broader level. Reference Uehling, Hall-Clifford, Kinnard and Wimberly18 Understanding definitions of health equity terminology can be an important first step toward identifying and differentiating health disparities and inequities occurring in our field (Table 1). However, clinicians and researchers need to move beyond mere documentation toward identification, investigation, and mitigation of these upstream drivers leading to the observed disparities. The purposes of this commentary are (1) to provide context for why health equity is important in healthcare epidemiology, infection prevention, and antimicrobial stewardship and (2) to share action steps for individuals, institutions, and health systems.

Table 1. Definitions of Health Equity Terminology a

a For additional definitions visit the CDC National Center for Chronic Disease Prevention & Health Promotion, NCCDPHP Health Equity Glossary. (https://www.cdc.gov/chronicdisease/healthequity/health-equity-communications/nccdphp-health-equity-glossary.html, last reviewed December 8, 2022, and accessed November 6, 2023).

How social determinants of health (SDOH) interact to cause and exacerbate disparities within infectious diseases

Social determinants of health (SDOH) are defined as the nonmedical factors that influence health outcomes including (but not limited to) education quality, economic stability, neighborhood, housing environment, and healthcare access. Reference Brown and Homan19 Many disparities observed in clinical outcomes among patients from minoritized backgrounds are likely driven by inequities in these factors, as well as additional systems of oppression that may themselves be considered separate SDOH (ie, racism, homophobia, ableism, sexism, and ageism). Reference Marcelin, Swartz and Bernice20 These factors can influence patient outcomes from infectious diseases.

For example, differences in access to quality educational opportunities can contribute to lower levels of literacy, which can severely affect the degree to which individuals can find, understand, and use information to inform their health-specific literacy or health-related decision making. Reference Hickey, Masterson Creber and Reading21Reference Prince, Schmidtke, Beck and Hadden23 More than 80 million American adults have low health literacy, with disproportionately higher representation among older adults and people from racially and ethnically minoritized backgrounds. Reference Prince, Schmidtke, Beck and Hadden23 Historical racial residential segregation has played a significant role in these inequities due to artificial limitations on quality educational access and in some cases, poorly funded education systems. Moreover, the specter of racism in healthcare with historical and contemporaneous medical mistreatment has resulted in justified healthcare mistrust across communities of racially and ethnically minoritized backgrounds. Several examples are well-known, such as the US Public Health Service–funded study of untreated syphilis in Black men at the Tuskegee Institute, the unauthorized retrieval and profits from the use of Mrs. Henrietta Lacks’ cervical cells without her consent, and the compulsory sterilization of Native American women at Indian Health Services hospitals. Reference Marcelin, Swartz and Bernice20,Reference Scharff, Mathews, Jackson, Hoffsuemmer, Martin and Edwards24,Reference Lawrence25 This mistrust can interfere with health literacy development because it can influence interactions with access to healthcare-related resources and overall health decision making. Reference Elam-Evans, Jones and Vashist26,Reference Felton, Rabinowitz and Strickland27 For example, during the COVID-19 pandemic, people from racially and ethnically minoritized backgrounds were disproportionately represented in rates of disease, hospitalization, and death from SARS-CoV-2, yet, once vaccines were available, these groups were the least represented among persons who received the COVID-19 vaccine. Reference Kriss, Hung and Srivastav28Reference Rossen, Ahmad and Anderson30 Higher reliance on social media as a source of COVID-19 education was noted among people from racially and ethnically minoritized groups, and widespread misinformation and disinformation campaigns on these platforms may have resulted in compromised health literacy, adversely impacting healthcare decision making. Reference Goldsmith, Rowland-Pomp and Hanson31

Furthermore, inadequate options to appropriately communicate with individuals with limited English proficiency also compromise health literacy and negatively influence outcomes for those patient populations. Individuals with limited English proficiency experience barriers to accessing healthcare coverage, which may delay treatment seeking and the receipt of appropriate care. Reference Foiles Sifuentes, Robledo Cornejo, Li, Castaneda-Avila, Tjia and Lapane32 These inequities likely have major downstream effects, including longer emergency room visits and hospital admissions in pediatric and adult patients who speak a language other than English. Reference Goldman, Amin and Macpherson33,Reference Karliner, Kim, Meltzer and Auerbach34 Differences in infection prevalence, due to language barriers, have also been observed among pediatric populations. Higher rates of central-line–related bloodstream infections (CLABSIs) have been documented in pediatric patients with limited English proficiency. Reference McGrath, Bettinger and Stimpson35 Reducing the negative impacts of language barriers in infection prevention and antimicrobial stewardship is essential for HAI prevention, especially given the importance of patient education (eg, preoperative chlorhexidine bathing or wound care and antibiotic education at patient discharge). Reference Prochaska, Caballero, Fabre and Milstone12

Biases in hiring policies and practices as well as inequities in access to quality education and lower rates of advanced education result in a disproportionately high representation of individuals from minoritized backgrounds in low-wage employment. These biases likely contribute to the disproportionate high levels of social and economic vulnerability, including low socioeconomic status (SES) observed across groups from minoritized backgrounds, compared with individuals from privileged backgrounds less harmed by racism. Reference Weller36 Because employment guides monetary income, and income is required for housing, higher proportions of people from racially and ethnically minoritized backgrounds reportedly live in multigenerational or overcrowded housing, which may facilitate infection transmission through close contact. Reference Marcelin, Swartz and Bernice20 This situation was highlighted during the COVID-19 pandemic. People from racially or ethnically minoritized backgrounds were more likely to work in lower-income healthcare personnel roles (eg, certified nursing assistants and medical assistants) and were at higher risk of contracting COVID-19 due to presumed increased exposures in either or both work and nonwork settings. Reference Zlotorzynska, Chea and Eure16

Low SES can influence access to healthcare, which further exacerbates disparities in infectious diseases. For example, disproportionate rates of Clostridium difficile infection (CDI) have been frequently reported in individuals who reside in areas of low SES when compared to those who live in areas of higher SES. Reference Argamany, Delgado and Reveles37Reference Skrobarcek, Mu and Ahern39 People who are uninsured or underinsured may experience challenges that hinder their ability to receive care for the management of chronic illnesses, which may subsequently increase their risk of infectious complications. Reference Mao, Kelly and Machan40 Patients from racially and ethnically minoritized backgrounds who were diagnosed with CDI at a hospital serving primarily low SES communities were more likely to be under- or uninsured. Reference Lee, Zhou, Ortiz-Gratacos, Al Isso, Tan and Abdul-Mutakabbir8 They were also more likely to have been diagnosed with diabetes and chronic kidney disease (CKD), and a pre-existing CKD diagnosis contributed to the increased odds of severe CDI seen in minoritized patients. Reference Lee, Zhou, Ortiz-Gratacos, Al Isso, Tan and Abdul-Mutakabbir8 This gap will likely continue to widen as areas of low SES are less likely to have an adequate number of healthcare resources and/or professionals to provide necessary services.

Challenges with identifying and mitigating health inequities in infection prevention and antimicrobial stewardship

Several challenges exist in identifying and mitigating health inequities in infection prevention and antimicrobial stewardship. These can be broadly grouped into themes including (1) diversity of the healthcare workforce and patient access to clinicians, where many minoritized communities are underrepresented, and (2) challenges with availability and quality of data, affecting patient care and community health outcomes.

Challenges with healthcare workforce diversity and access

Patient–clinician cultural concordance can promote positive clinical outcomes, demonstrating that a diverse healthcare epidemiology, infection prevention, and antimicrobial stewardship workforce is essential to mitigate health inequities and serve diverse populations. Reference Shen, Peterson and Costas-Muñiz41 Black, Hispanic/Latino, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander individuals are underrepresented as trainees and practicing physicians in the United States relative to their census demographics. Reference Cichon, Green, Hilker and Inclusion42Reference Rogo, Holland and Fassiotto45 Furthermore, individuals with these minoritized racial and ethnic identities are underrepresented in leadership positions, Reference Marcelin, Manne-Goehler and Silver44 have fewer speaking opportunities at national conferences, Reference Marcelin, Khazanchi and Lyden46,Reference Wiley, Kalu and Lyden47 and experience lower pay. Reference Marcelin, Bares and Fadul48 Intentional efforts to address leadership and speaking opportunities for women have led to improvements in gender equity Reference Marcelin, Manne-Goehler and Silver44,Reference Marcelin, Khazanchi and Lyden46,Reference Aberg, Blankson, Marrazzo and Adimora49 ; however, gaps remain related to pay Reference Marcelin, Bares and Fadul48 and promotion. Reference Manne-Goehler, Krakower, Marcelin, Salles, Del Rio and Stead50Reference Stead, Manne-Goehler and Blackshear52

Many of these gaps reported for physicians undoubtedly exist for other healthcare team members such as pharmacists, infection preventionists, advanced practice clinicians, etc; however, data from these professional groups are sparse. Reference Abdul-Mutakabbir, Arya and Butler53Reference Bissell, Johnston and Smith56 Furthermore, there is a dearth of data describing the contribution and impacts of infectious disease healthcare workers from lesbian, gay, bisexual, transgender, queer and nonbinary gender (LGBTQ+) communities or healthcare workers with disabilities. To address these gaps, medical societies can commit to identifying and mitigating these workforce inequities through coordinated strategies, Reference Marcelin, Khazanchi and Lyden46,Reference Wiley, Kalu and Lyden47 ranging from intentional recruitment to retention and recognition. Concurrent with existing efforts to inspire interest in infectious diseases (ID), pathway programs (starting as early as elementary school) can expose young learners to ID careers, and their development and execution should be intentional to ensure that individuals from backgrounds historically excluded have access to these career opportunities. Reference Rogo, Holland and Fassiotto57

Ensuring an adequate workforce serving rural and community hospitals is also necessary. Patients in smaller community hospitals, particularly in the Southeastern United States, were disproportionately affected by CDI, catheter-associated urinary tract infections (CAUTIs), and CLABSIs during the height of the COVID-19 pandemic. Reference Advani, Sickbert-Bennett and Moehring58 Children living in rural counties (compared to children living in urban counties) have increased rates of inappropriate antibiotic use. Reference Dantuluri, Bruce and Edwards59 To address these geographic differences in HAIs and antibiotic prescribing quality, improving access to ID expertise (local or telehealth) is warranted to serve smaller rural community hospitals. Reference Livorsi, Abdel-Massih and Crnich60 Academic healthcare facilities are often overrepresented in research, limiting the generalization of published data, with inadvertent exclusion of rural populations. In a survey assessing collection of SDOH data as a routine part of HAI surveillance in US-based hospitals, 7 (27%) of 26 responding facilities represented community hospitals and only 4 (16%) included public and federal hospitals. Reference McGrath, Logan and Deloney10 Furthermore, of the responding facilities, only 1 (4%) of 26 responding facilities were from Western states (11 were from Southern states), which likely influenced the inclusion of indigenous persons living in Western states in these studies. Only 8 (30%) of 27 facilities collected SDOH patient variables and, of these 8 facilities, 7 (88%) were academic centers. Reference McGrath, Logan and Deloney10 More than 70% of US hospitals have <200 beds, and many of these facilities serve communities in need and those from minoritized communities. Reference Mena Lora, Echeverria and Lindsey11,Reference Stenehjem, Hyun and Septimus61

Inclusive cultures must be developed and fostered during health professions training and patient care, Reference Flores, Tan and Bryant43,Reference Rogo, Holland and Fassiotto45,Reference Essien, Agbafe and Norris62 as well as through intentional assembly of healthcare epidemiology–infection prevention–antimicrobial stewardship teams to include intersectional identities. Unconscious or implicit bias describes “associations or attitudes that reflexively alter our perceptions, thereby affecting behavior, interactions, and decision making,” Reference Marcelin, Siraj, Victor, Kotadia and Maldonado63 and can contribute to inequities in antimicrobial stewardship. In one study, female antimicrobial stewardship pharmacists were less likely to have their antibiotic recommendations accepted by prescribing clinicians than male antimicrobial stewardship pharmacists. Reference Vaughn, Giesler and Mashrah14 Approaches to counter unconscious bias are multidimensional; however, at the core they operate in conjunction with methods to increase diversity, equity, and inclusion, which includes diversifying the healthcare workforce. Reference Marcelin, Manne-Goehler and Silver44,Reference Marcelin, Siraj, Victor, Kotadia and Maldonado63

The case for supporting equity, diversity, inclusion, and access in the antimicrobial stewardship and infection prevention workforce is multifaceted. In addition to greater opportunity for clinician–patient concordant relationships, some data have demonstrated that diverse teams function better and are more successful in research. Reference Miller and Del Carmen Triana64 Diverse teams produced more innovative research and published in higher-impact journals, which may allow for an increase in the dissemination of the innovative findings. Reference Yang, Tian, Woodruff, Jones and Uzzi65 Importantly, addressing healthcare workforce inequities contributes directly to improved patient care. Reference Snyder, Upton, Hassett, Lee, Nouri and Dill66

Challenges with availability and quality of data

Medical research typically captures demographic information on sex, age, race, and ethnicity, but addressing inequities is rarely the objective, which prompted a call to expand the literature evaluating inequities in HAI incidence. Reference Kim, Kabbani and Dube17,Reference Chen, Khazanchi, Bearman and Marcelin67,Reference Evans and Wiley68 In a scoping review of health-equity antibiotic prescribing studies, only 23% of studies reported a specific equity objective, whereas 48% of the included studies reported patient or prescriber characteristics. Reference Kim, Kabbani and Dube17 Among studies reporting any health equity markers, people from racial and ethnic minoritized groups were less likely to receive antibiotics overall Reference Wattles, Jawad and Feygin15,Reference Gerber, Prasad and Localio69 or were less likely to receive firstline antibiotic treatment. Reference Wurcel, Essien and Ortiz70 Further disparities were observed based on geographic location, with higher antibiotic prescribing in southern regions Reference Goodman, Baghdadi and Magder71 and rural areas. Reference Dantuluri, Bruce and Edwards59 Additionally, socioeconomic status also influenced equitable prescribing; privately insured people were more likely to receive antibiotics compared with the uninsured. Reference Hersh, Shapiro, Pavia and Shah72 Despite these disparities, research regarding potential drivers (or upstream causes) of observed disparities is lacking. Reference Kim, Kabbani and Dube17

Recent studies have evaluated disparities related to multidrug resistance, infection prevention efforts and outbreak response, HAIs, and specific conditions, including candidemia, CDI, and COVID-19. Reference Brown, Henderson, Ruegsegger, Moody and van Duin4Reference Lee, Zhou, Ortiz-Gratacos, Al Isso, Tan and Abdul-Mutakabbir8,Reference Prochaska, Caballero, Fabre and Milstone12,Reference Schrodt, Hart, Calanan, McLees, Perz and Perkins13,Reference Zlotorzynska, Chea and Eure16,Reference McGrath, Bettinger and Stimpson35,Reference O’Halloran, Holstein and Cummings73 Data regarding health inequities in inpatient antibiotic prescribing are very limited. Kim et al Reference Kim, Kabbani and Dube17 reported that 55 (90%) of 61 articles in their scoping review described outpatient settings and only 1 (1.6%) was from the acute-care setting. Their review also noted very few stewardship intervention studies, only 4 (6.6%) of 61 studies. Reference Kim, Kabbani and Dube17 Considering that patients who are uninsured and underinsured often do not have access to outpatient clinics and may use the emergency department or hospital as their only form of healthcare, the lack of published data in the inpatient setting is a significant limitation in the consideration of health inequities in antibiotic prescribing.

As researchers evaluate these disparities, even within what many consider to be basic demographic variables, they must be aware of how they are collecting the information and what methodologic biases may be introduced. For example, age is quantifiable, but age stratification (eg, who are considered “older adults”) and how disparities in infection incidence and antimicrobial use affect various age categories are all important considerations for researchers. Accurate identification of sex, race, and ethnicity is also key for both clinicians and researchers. Gender identity and biological sex are different constructs, and knowledge of both are necessary not only to provide high-level medical care but also to perform quality research, especially when disparities might exist among different groups. 74 Clinicians and researchers also tend to make assumptions about race and ethnicity that may not align with their patients’ and study participants’ self-identified race and ethnicity, especially when these characteristics are limited to finite categories. Reference Agawu, Chaiyachati, Radack, Duncan and Ellison75 Such assumptions can affect the care these patients receive if clinicians’ implicit racial biases translate into decision making either consciously or subconsciously and can in turn affect study analyses on racial disparities in infectious diseases. Race and ethnicity are sociopolitical, not biological constructs; therefore, they should not be used in clinical practice to make inferences about physiologic function. Care should be taken in research to understand structural barriers causing racialized disparities rather than assigning race itself as a risk factor. Reference Cerdeña, Plaisime and Tsai76Reference Boyd, Lindo, Weeks and McLemore79

Finally, some SDOH variables are often not collected or are overlooked in medical research, such as disability status and housing or food insecurity. The charge to incorporate such variables into medical research extends beyond the individual clinician and researcher. Regulatory and government agencies should consider these when determining standard metrics for reportable infectious diseases and conditions. The National Healthcare Safety Network (NHSN) captures HAI and antimicrobial use data from acute and postacute care facilities. 80 HAI case reporters can include race and ethnicity data, but the field is optional. The antimicrobial use module captures only aggregate facility-level or unit-level information. Although this information may be helpful to assess facility-level interventions, analysis of disparities in care or prescribing based on age, gender, race, or ethnicity cannot be performed.

Next steps and call to action

Prioritizing elimination of healthcare disparities requires individual, institutional, and public health level interventions. Here, we provide actionable recommendations for mitigating the equity gaps at each level (Fig. 1).

Figure 1. Actions for individuals, institutions, and public health organizations to mitigate impacts of health inequities.

Individuals

A starting point for clinicians is an urgent commitment to creating a culture of equity and inclusion in healthcare spaces (Fig. 1). To create environments that provide patients and staff with what they need to succeed through a lens of equity, thorough assessments of individual practices should be conducted to determine areas of greatest need. For example, Fortin-Leung et al Reference Fortin-Leung and Wiley81 raised questions about the paucity of race and ethnicity data built into antimicrobial stewardship programs. Acknowledging that patient-level characteristics from birth to death can affect antimicrobial prescribing, use, and administration, they suggested that prescribers could seek to understand how cultural differences along racial, ethnic or gender lines affect nonprescription antibiotic use, medication adherence, and drive differences in prescribing behavior.

Because SDOH may have varying impacts on patient health, healthcare personnel should intentionally seek out education on the impact of SDOH and SES on patient health. Reference Brown, Henderson, Ruegsegger, Moody and van Duin4 Healthcare professionals remain the most trusted sources of health information in our current era of declining health literacy and access to high-quality health information. Staying appropriately informed can help clinicians maintain this trust and properly advocate for patients. Patient advocacy may be strengthened by recruiting and retaining a diverse workforce. Through mentorship and sponsorship for people from different backgrounds, healthcare personnel can prioritize support for successful career advancement.

Organizational

Healthcare systems and facility leadership are responsible for creating a culture of equity in their institutions. 82 Steps to be taken at institutions include the following: (1) assessing whether care delivery is equitable; (2) prioritizing quality improvement interventions that address differential care delivery; (3) providing high-quality health equity and implicit bias training for healthcare professionals; (4) leveraging data for individual-level clinician feedback on health equity measures; and (5) making public statements of goals and actions to improve equity, in addition to internal commitments (Fig. 1). For example, during the COVID-19 pandemic, infectious disease, and antimicrobial stewardship leadership at one hospital recognized that access to monoclonal antibody infusion for COVID-19 management was inequitable. They leveraged an emergency department fast-track location and existing staff to make the treatment available for an underserved community. Reference Mena Lora, Echeverria and Lindsey11

Sustainable measures to mitigate disparities require accountability. Public and private institutions, including societies dedicated to healthcare epidemiology and antibiotic stewardship, have made public declarations of diversity equity and inclusion commitments. 83,84 Yet, without high-quality data collection and publicized data reviews, accountability may not be feasible for health systems. Reference McGrath, Logan and Deloney10 Additionally, the validity of SDOH, race, and ethnicity data entered into the electronic health record (EHR) have often been called into question, creating challenges for collecting and interpreting HAI inequity data. Reference Agawu, Chaiyachati, Radack, Duncan and Ellison75 However, interventions to correct these patterns might have limited impact in the absence of data validity tools for EHR systems to capture accurate data points. Despite these challenges, healthcare institutions can still develop anchor missions focused on addressing inequities for their local communities. For example, a Chicago-based health system crafted a multipronged framework that named racism and poverty as targeted causes of inequities. They embarked on a health equity mission to invest locally, collaborated with their surrounding community across all care spectrums, and they developed performance improvement plans to improve their patient outcomes. Reference Ansell, Oliver-Hightower, Goodman, Lateef and Johnson85 The level of commitment to equity may not be replicable for every institution, but we recommend that institutions identify and tackle a singular equity mission that is achievable and feasible within an established timeline. Healthcare system and facility leadership should be purposeful in recruiting a diverse and skilled workforce in healthcare epidemiology, infection prevention, and antimicrobial stewardship. Institutions can frequently conduct equity reviews and proactively correct identified deficiencies.

Public health systems

Public health engagement at the federal, state, and local levels is needed to address health inequities (Fig. 1). National, state, and community policies, structural inequities, and differential access to reliable information sources are important factors. The COVID-19 pandemic revealed the need for future public health initiatives to address systematic inequalities that can perpetuate and lead to differences in population and individual outcomes. Reference Li, Cai, Mao, Cheng and Temkin-Greener9 Action steps for public health include the following: (1) requiring surveillance and research activities that include health equity objectives and capture the needed data to support decision making and implementation science to address inequities; (2) providing necessary analytic resources to help characterize health inequities at the national, community, healthcare system, and facility levels to provide a compass for where action is needed; (3) communicating health information effectively to a variety of different audiences and health literacy levels; (4) facilitating access to subject matter expertise in healthcare epidemiology, infection prevention, antibiotic stewardship in health departments across the country; and (5) incorporating a health equity lens into guidance and policies for healthcare epidemiology, infection prevention, and antibiotic stewardship implementation. Regulatory and accreditation partners, such as The Joint Commission, can facilitate policy change. For example, in 2023 new health equity standards were released by The Joint Commission to establish a new baseline of equitable delivery of healthcare. 86

In conclusion, inequities in healthcare occur at every resource level. Steps to advance health equity should be considered at every level, whether a well-resourced health system or a rural critical-access hospital. Advancing health equity includes delivery of safe and equitable patient care and recruiting individuals with diverse backgrounds to healthcare epidemiology, infection prevention, and antimicrobial stewardship career paths.

Acknowledgments

The authors thank Heather Clayton, Senior Advisor for Health Equity, Division of Healthcare Quality and Promotion, CDC, for her thoughtful review. The authors also thank Toni Goeser, who created the artwork for Figure 1. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.

Financial support

No financial support was provided relevant to this article.

Competing interests

I.B.K. reports grant funding from Center for Disease Control and Prevention (CDC) Epicenter, National Institutes of Health (NIH), Bristol Myers Squibb Foundation, and receives consultancy fees from IPEC Experts and Wayfair, all unrelated to this manuscript. Z.W. is a volunteer member and Chair of the SHEA Education Committee. She also participated in the advisory board for Entasis Therapeutics and received an honorarium in 2022. J.A.M. receives support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH award no. K12HD113189). J.A.M. has also participated in advisory board for Shionogi Entasis Therapeutics, CSL Sequiris, Abbvie, GSK, and Novavax and has received honoraria. She is also an appointed member of the CVSH National Health Equity Advisory Board. All other authors have nothing to disclose relevant to this publication.

References

What is Health Equity? Centers for Disease Control and Prevention website. https://www.cdc.gov/healthequity/index.html. Accessed November 6, 2023.Google Scholar
Braveman, P, Gruskin, S. Defining equity in health. J Epidemiol Comm Health 2003;57:254258.CrossRefGoogle ScholarPubMed
People, Healthy 2030. How do healthy people define health equity and health disparities? https://health.gov/healthypeople/priority-areas/health-equity-healthy-people-2030. Accessed October 21, 2023.Google Scholar
Brown, DR, Henderson, HI, Ruegsegger, L, Moody, J, van Duin, D. Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales. Infect Control Hosp Epidemiol 2023;44:20682070.CrossRefGoogle ScholarPubMed
Gettler, EB, Kalu, IC, Okeke, NL, et al. Disparities in central-line–associated bloodstream infection and catheter-associated urinary tract infection rates: an exploratory analysis. Infect Control Hosp Epidemiol 2023;44:18571860.CrossRefGoogle ScholarPubMed
Grant, VC, Zhou, AY, Tan, KK, Abdul-Mutakabbir, JC. Racial disparities among candidemic patients at a Southern California teaching hospital. Infect Control Hosp Epidemiol 2023;44:18661869.CrossRefGoogle Scholar
Guo, W, Li, Y, Temkin-Greener, H. Coronavirus disease 2019 (COVID-19) in assisted living communities: neighborhood deprivation and state social distancing policies matter. Infect Control Hosp Epidemiol 2022;43:10041009.CrossRefGoogle ScholarPubMed
Lee, JM, Zhou, AY, Ortiz-Gratacos, NM, Al Isso, A, Tan, KK, Abdul-Mutakabbir, JC. Examining the impact of racial disparities on Clostridioides difficile infection outcomes at a Southern California academic teaching hospital. Infect Control Hosp Epidemiol 2023. doi: 10.1017/ice.2023.84.CrossRefGoogle Scholar
Li, Y, Cai, X, Mao, Y, Cheng, Z, Temkin-Greener, H. Trends in racial and ethnic disparities in coronavirus disease 2019 (COVID-19) outcomes among nursing home residents. Infect Control Hosp Epidemiol 2022;43:9971003.CrossRefGoogle ScholarPubMed
McGrath, CL, Logan, LK, Deloney, VM, et al. Monitoring health disparities in healthcare-associated infection surveillance: a Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN) survey. Infect Control Hosp Epidemiol 2023. doi: 10.1017/ice.2023.181.CrossRefGoogle Scholar
Mena Lora, AJ, Echeverria, SL, Lindsey, B, et al. Feasibility and impact of a monoclonal antibody infusion program in reaching vulnerable underserved communities. Infect Control Hosp Epidemiol 2023;44:16901692.CrossRefGoogle ScholarPubMed
Prochaska, EC, Caballero, TM, Fabre, V, Milstone, AM. Infection prevention requires attention to patient and caregiver language: removing language barriers from infection prevention education. Infect Control Hosp Epidemiol 2023;44:17071710.CrossRefGoogle ScholarPubMed
Schrodt, CA, Hart, AM, Calanan, RM, McLees, AW, Perz, JF, Perkins, KM. Health equity: the missing data elements in healthcare outbreak response. Infect Control Hosp Epidemiol 2023;44:849850.CrossRefGoogle ScholarPubMed
Vaughn, VM, Giesler, DL, Mashrah, D, et al. Pharmacist gender and physician acceptance of antibiotic stewardship recommendations: an analysis of the reducing overuse of antibiotics at discharge home intervention. Infect Control Hosp Epidemiol 2023;44:570577.CrossRefGoogle ScholarPubMed
Wattles, BA, Jawad, KS, Feygin, Y, et al. Inappropriate outpatient antibiotic use in children insured by Kentucky Medicaid. Infect Control Hosp Epidemiol 2022;43:582588.CrossRefGoogle ScholarPubMed
Zlotorzynska, M, Chea, N, Eure, T, et al. Residential social vulnerability among healthcare personnel with and without severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in five US states, May–December 2020. Infect Control Hosp Epidemiol 2024;45:8288.CrossRefGoogle ScholarPubMed
Kim, C, Kabbani, S, Dube, WC, et al. Health equity and antibiotic prescribing in the United States: a systematic scoping review. Open Forum Infect Dis 2023;10:ofad440.CrossRefGoogle ScholarPubMed
Uehling, M, Hall-Clifford, R, Kinnard, C, Wimberly, Y. Advancing equity in US hospital systems: employee understandings of health equity and steps for improvement. J Healthc Manag 2023;68:342355.Google ScholarPubMed
Brown, TH, Homan, P. The future of social determinants of health: looking upstream to structural drivers. Milbank Q 2023;101 suppl 1:3660.CrossRefGoogle Scholar
Marcelin, JR, Swartz, TH, Bernice, F, et al. Addressing and inspiring vaccine confidence in black, indigenous, and people of color during the coronavirus disease 2019 pandemic. Open Forum Infect Dis 2021;8:ofab417.CrossRefGoogle ScholarPubMed
Hickey, KT, Masterson Creber, RM, Reading, M, et al. Low health literacy: implications for managing cardiac patients in practice. Nurse Pract 2018;43:4955.CrossRefGoogle ScholarPubMed
Muvuka, B, Combs, RM, Ayangeakaa, SD, Ali, NM, Wendel, ML, Jackson, T. Health literacy in African-American communities: barriers and strategies. Health Lit Res Pract 2020;4:e138e143.Google ScholarPubMed
Prince, LY, Schmidtke, C, Beck, JK, Hadden, KB. An assessment of organizational health literacy practices at an academic health center. Qual Manag Health Care 2018;27:9397.CrossRefGoogle ScholarPubMed
Scharff, DP, Mathews, KJ, Jackson, P, Hoffsuemmer, J, Martin, E, Edwards, D. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved 2010;21:879897.CrossRefGoogle ScholarPubMed
Lawrence, J. The Indian Health Service and the sterilization of Native American women. Am Indian Q 2000;24:400419.CrossRefGoogle ScholarPubMed
Elam-Evans, LD, Jones, CP, Vashist, K, et al. The association of reported experiences of racial and ethnic discrimination in health care with COVID-19 vaccination status and intent—United States, April 22, 2021–November 26, 2022. Morb Mortal Wkly Rep 2023;72:437444.CrossRefGoogle Scholar
Felton, JW, Rabinowitz, JA, Strickland, JC, et al. Social vulnerability, COVID-19 impact, and decision making among adults in a low-resource community. Behav Processes 2022;200:104668.CrossRefGoogle Scholar
Kriss, JL, Hung, MC, Srivastav, A, et al. COVID-19 vaccination coverage, by race and ethnicity—national immunization survey adult COVID module, United States, December 2020–November 2021. Morb Mortal Wkly Rep 2022;71:757763.CrossRefGoogle Scholar
Moore, JT, Ricaldi, JN, Rose, CE, et al. Disparities in incidence of COVID-19 among underrepresented racial/ethnic groups in counties identified as hotspots during June 5–18, 2020—22 States, February–June 2020. Morb Mortal Wkly Rep 2020;69:11221126.CrossRefGoogle ScholarPubMed
Rossen, LM, Ahmad, FB, Anderson, RN, et al. Disparities in excess mortality associated with COVID-19—United States, 2020. Morb Mortal Wkly Rep 2021;70:11141119.CrossRefGoogle Scholar
Goldsmith, LP, Rowland-Pomp, M, Hanson, K, et al. Use of social media platforms by migrant and ethnic minority populations during the COVID-19 pandemic: a systematic review. BMJ Open 2022;12:e061896.CrossRefGoogle ScholarPubMed
Foiles Sifuentes, AM, Robledo Cornejo, M, Li, NC, Castaneda-Avila, MA, Tjia, J, Lapane, KL. The role of limited english proficiency and access to health insurance and health care in the Affordable Care Act era. Health Equity 2020;4:509517.CrossRefGoogle ScholarPubMed
Goldman, RD, Amin, P, Macpherson, A. Language and length of stay in the pediatric emergency department. Pediatr Emergency Care 2006;22:640643.CrossRefGoogle ScholarPubMed
Karliner, LS, Kim, SE, Meltzer, DO, Auerbach, AD. Influence of language barriers on outcomes of hospital care for general medicine inpatients. J Hosp Med 2010;5:276282.CrossRefGoogle ScholarPubMed
McGrath, CL, Bettinger, B, Stimpson, M, et al. Identifying and mitigating disparities in central-line–associated bloodstream infections in minoritized racial, ethnic, and language groups. JAMA Pediatr 2023;177:700709.CrossRefGoogle ScholarPubMed
Weller, CE. African Americans face systematic obstacles to getting good jobs. American Progress website. https://www.americanprogress.org/article/african-americans-face-systematic-obstacles-getting-good-jobs/. Accessed October 21, 2023.Google Scholar
Argamany, JR, Delgado, A, Reveles, KR. Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010. BMC Infect Dis 2016;16:454.CrossRefGoogle ScholarPubMed
Hudspeth, WB, Qeadan, F, Phipps, EC. Disparities in the incidence of community-acquired Clostridioides difficile infection: an area-based assessment of the role of social determinants in Bernalillo County, New Mexico. Am J Infect Control 2019;47:773779.CrossRefGoogle ScholarPubMed
Skrobarcek, KA, Mu, Y, Ahern, J, et al. Association between socioeconomic status and incidence of community-associated Clostridioides difficile infection—United States, 2014–2015. Clin Infect Dis 2021;73:722725.CrossRefGoogle ScholarPubMed
Mao, EJ, Kelly, CR, Machan, JT. Racial differences in Clostridium difficile infection rates are attributable to disparities in healthcare access. Antimicrob Agents Chemother 2015;59:62836287.CrossRefGoogle Scholar
Shen, MJ, Peterson, EB, Costas-Muñiz, R, et al. The effects of race and racial concordance on patient–physician communication: a systematic review of the literature. J Racial Ethn Health Dispar 2018;5:117140.CrossRefGoogle ScholarPubMed
Cichon, CJ, Green, EC, Hilker, E, Inclusion, Marcelin JR., diversity, access, and equity in antimicrobial stewardship: where we are and where we are headed. Curr Opin Infect Dis 2023;36:281287.CrossRefGoogle ScholarPubMed
Flores, AR, Tan, TQ, Bryant, KA. Creating a diverse and inclusive pediatric infectious diseases workforce. J Pediatr Infect Dis Soc 2022;11 suppl 4:S125S126.CrossRefGoogle ScholarPubMed
Marcelin, JR, Manne-Goehler, J, Silver, JK. Supporting inclusion, diversity, access, and equity in the infectious disease workforce. J Infect Dis 2019;220 suppl 2:S50S61.CrossRefGoogle ScholarPubMed
Rogo, T, Holland, S, Fassiotto, M, et al. Strategies to increase workforce diversity in pediatric infectious diseases. J Pediatr Infect Dis Soc 2022;11 suppl 4:S148S154.CrossRefGoogle ScholarPubMed
Marcelin, JR, Khazanchi, R, Lyden, E, et al. Demographic representation among speakers and program committee members at the IDWeek conference, 2013–2021. Clin Infect Dis 2023;76:897904.CrossRefGoogle ScholarPubMed
Wiley, Z, Kalu, IC, Lyden, E, et al. Demographic representation among speakers at the Society for Healthcare Epidemiology of America (SHEA) spring conferences. Infect Control Hosp Epidemiol 2023:17.CrossRefGoogle Scholar
Marcelin, JR, Bares, SH, Fadul, N. Improved infectious diseases physician compensation but continued disparities for women and underrepresented minorities. Open Forum Infect Dis 2019;6:ofz042.CrossRefGoogle ScholarPubMed
Aberg, JA, Blankson, J, Marrazzo, J, Adimora, AA. Diversity in the US infectious diseases workforce: challenges for women and underrepresented minorities. J Infect Dis 2017;216 suppl 5:S606S610.CrossRefGoogle Scholar
Manne-Goehler, J, Krakower, D, Marcelin, J, Salles, A, Del Rio, C, Stead, W. Peering through the glass ceiling: a mixed methods study of faculty perceptions of gender barriers to academic advancement in infectious diseases. J Infect Dis 2020;222 suppl 6:S528S534.CrossRefGoogle Scholar
Manne-Goehler, J, Kapoor, N, Blumenthal, DM, Stead, W. Sex differences in achievement and faculty rank in academic infectious diseases. Clin Infect Dis 2020;70:290296.CrossRefGoogle ScholarPubMed
Stead, W, Manne-Goehler, J, Blackshear, L, et al. Wondering if I’d get there quicker if I was a man: factors contributing to delayed academic advancement of women in infectious diseases. Open Forum Infect Dis 2023;10:ofac660.CrossRefGoogle Scholar
Abdul-Mutakabbir, JC, Arya, V, Butler, L. Acknowledging the intersection of gender inequity and racism: identifying a path forward in pharmacy. Am J Health Syst Pharm 2022;79:696700.CrossRefGoogle ScholarPubMed
Allen, JM, Abdul-Mutakabbir, JC, Campbell, HE, Butler, LM. Ten recommendations to increase Black representation within pharmacy organization leadership. Am J Health Syst Pharm 2021;78:896902.CrossRefGoogle ScholarPubMed
Bakken, BK, Oudeh, R, Gaither, CA, et al. Leadership aspiration: an intersectional analysis of racial and gender equity in pharmacy. J Am Pharm Assoc 2023;63:8089.CrossRefGoogle ScholarPubMed
Bissell, BD, Johnston, JP, Smith, RR, et al. Gender inequity and sexual harassment in the pharmacy profession: evidence and call to action. Am J Health Syst Pharm 2021;78:20592076.CrossRefGoogle ScholarPubMed
Rogo, T, Holland, S, Fassiotto, M, et al. Strategies to increase workforce diversity in pediatric infectious diseases. J Pediatr Infect Dis Soc 2022;11 suppl 4:S148S154.CrossRefGoogle Scholar
Advani, SD, Sickbert-Bennett, E, Moehring, R, et al. The disproportionate impact of coronavirus disease 2019 (COVID-19) pandemic on healthcare-associated infections in community hospitals: need for expanding the infectious disease workforce. Clin Infect Dis 2023;76:e34e41.CrossRefGoogle ScholarPubMed
Dantuluri, KL, Bruce, J, Edwards, KM, et al. Rurality of residence and inappropriate antibiotic use for acute respiratory infections among young Tennessee children. Open Forum Infect Dis 2021;8:ofaa587.CrossRefGoogle ScholarPubMed
Livorsi, DJ, Abdel-Massih, R, Crnich, CJ, et al. An implementation roadmap for establishing remote infectious disease specialist support for consultation and antibiotic stewardship in resource-limited settings. Open Forum Infect Dis 2022;9:ofac588.CrossRefGoogle ScholarPubMed
Stenehjem, E, Hyun, DY, Septimus, E, et al. Antibiotic stewardship in small hospitals: barriers and potential solutions. Clin Infect Dis 2017;65:691696.CrossRefGoogle ScholarPubMed
Essien, UR, Agbafe, V, Norris, KC. Diversifying the medical pathway in a post–affirmative-action world. JAMA 2023;330:13251326.CrossRefGoogle Scholar
Marcelin, JR, Siraj, DS, Victor, R, Kotadia, S, Maldonado, YA. The impact of unconscious bias in healthcare: how to recognize and mitigate it. J Infect Dis 2019;220 suppl 2:S62S73.CrossRefGoogle Scholar
Miller, T, Del Carmen Triana, M. Demographic diversity in the boardroom: mediators of the board diversity–firm performance relationship. J Manage Stud 2009;46:755786.CrossRefGoogle Scholar
Yang, Y, Tian, TY, Woodruff, TK, Jones, BF, Uzzi, B. Gender-diverse teams produce more novel and higher-impact scientific ideas. Proc Natl Acad Sci U S A 2022;119:e2200841119.CrossRefGoogle ScholarPubMed
Snyder, JE, Upton, RD, Hassett, TC, Lee, H, Nouri, Z, Dill, M. Black representation in the primary care physician workforce and its association with population life expectancy and mortality rates in the US. JAMA Network Open 2023;6:e236687-e.CrossRefGoogle ScholarPubMed
Chen, J, Khazanchi, R, Bearman, G, Marcelin, JR. Racial/Ethnic inequities in healthcare-associated infections under the shadow of structural racism: narrative review and call to action. Curr Infect Dis Rep 2021;23:17.CrossRefGoogle ScholarPubMed
Evans, C, Wiley, Z. Demographic and geographic inequities in antimicrobial use and prescribing. Infect Dis Clin N Am 2023;37:715728.CrossRefGoogle ScholarPubMed
Gerber, JS, Prasad, PA, Localio, AR, et al. Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics 2013;131:677684.CrossRefGoogle ScholarPubMed
Wurcel, AG, Essien, UR, Ortiz, C, et al. Variation by race in antibiotics prescribed for hospitalized patients with skin and soft tissue infections. JAMA Netw Open 2021;4:e2140798.CrossRefGoogle ScholarPubMed
Goodman, KE, Baghdadi, JD, Magder, LS, et al. Patterns, predictors, and intercenter variability in empiric gram-negative antibiotic use across 928 United States hospitals. Clin Infect Dis 2023;76:e1224e1235.CrossRefGoogle ScholarPubMed
Hersh, AL, Shapiro, DJ, Pavia, AT, Shah, SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 2011;128:10531061.CrossRefGoogle ScholarPubMed
O’Halloran, AC, Holstein, R, Cummings, C, et al. Rates of influenza-associated hospitalization, intensive care unit admission, and in-hospital death by race and ethnicity in the United States From 2009 to 2019. JAMA Netw Open 2021;4:e2121880.CrossRefGoogle ScholarPubMed
Gender and health. World Health Organization website. https://www.who.int/health-topics/gender#tab=tab_1. Accessed November 6, 2023.Google Scholar
Agawu, A, Chaiyachati, BH, Radack, J, Duncan, AF, Ellison, A. Patterns of change in race category in the electronic medical record of a pediatric population. JAMA Pediatr 2023;177:536539.CrossRefGoogle ScholarPubMed
Cerdeña, JP, Plaisime, MV, Tsai, J. From race-based to race-conscious medicine: how anti-racist uprisings call us to act. Lancet 2020;396:11251128.CrossRefGoogle ScholarPubMed
Cerdeña, JP, Plaisime, MV, Tsai, J. Race-conscious medicine: a response to critique. Intern Med J 2021;51:13691370.CrossRefGoogle ScholarPubMed
Marcelin, JR, Fadul, N, Cawcutt, KA, Abdul-Mutakabbir, JC. Diversity in probiotics and diversity in clinical trials: opportunities for improvement. Infect Control Hosp Epidemiol 2022;43:15081509.CrossRefGoogle ScholarPubMed
Boyd, RW, Lindo, EG, Weeks, LD, McLemore, MR. On racism: a new standard for publishing on racial health inequities. Health Affairs Forefront 2020. doi: 10.1377/forefront.20200630.939347.Google Scholar
National Healthcare Safety Network (NHSN). Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/index.html. Accessed October 26, 2023.Google Scholar
Fortin-Leung, K, Wiley, Z. What about race and ethnicity in antimicrobial stewardship? Infect Control Hosp Epidemiol 2022;43:400401.CrossRefGoogle ScholarPubMed
Improving health equity: guidance for healthcare organizations. Institute for Healthcare Improvement website. https://www.ihi.org/resources/publications/improving-health-equity-guidance-health-care-organizations. Accessed November 21, 2023.Google Scholar
Inclusion, diversity, access and equity. Infectious Diseases Society of America website. https://www.idsociety.org/about-idsa/governance/inclusion-diversity-access-and-equity-idae-task-force/. Accessed October 21, 2023.Google Scholar
SHEA diversity, equity and inclusion pledge. Society for Healthcare Epidemiology of America website. https://shea-online.org/diversity-equity-inclusion-pledge/. Accessed October 21, 2023.Google Scholar
Ansell, DA, Oliver-Hightower, D, Goodman, LJ, Lateef, OB, Johnson, TJ. Health equity as a system strategy: the Rush University Medical Center framework. NEJM Catalyst 2021;2(5). doi: 10.1056/CAT.20.0674.CrossRefGoogle Scholar
Advancing healthcare equity, together. The Joint Commission website. https://www.jointcommission.org/our-priorities/health-care-equity/. Accessed October 21, 2023.Google Scholar
Jones, CP. How racism makes people sick: a conversation with Camara Phyllis Jones, MD, MPH, PhD. Kaiser Permanente Insitute for Health Policy website. https://www.kpihp.org/blog/how-racism-makes-people-sick-a-conversation-with-camara-phyllis-jones-md-mph-phd/. Accessed October 21, 2023.Google Scholar
Crenshaw, K. Mapping the margins: intersectionality, identity politics, and violence against women of color. Stanford Law Rev 1991;43:12411299.CrossRefGoogle Scholar
Social determinants of health at CDC. Centers for Disease Control and Prevention website. https://www.cdc.gov/about/sdoh/index.html. Accessed November 21, 2023.Google Scholar
Underrepresented in medicine definition. Association of American Medical Colleges website. https://www.aamc.org/what-we-do/equity-diversity-inclusion/underrepresented-in-medicine. Accessed November 6, 2023.Google Scholar
Essien, UR, Dusetzina, SB, Gellad, WF. A policy prescription for reducing health disparities—achieving pharmacoequity. JAMA 2021;326:17931794.CrossRefGoogle ScholarPubMed
Talking about anti-racism and health equity: describing identities and experiences. State Health and Value Strategies website. https://www.shvs.org/wp-content/uploads/2021/08/Talking-About-Anti-Racism-Health-Equity_Describing-Identities-3-of-3.pdf. Accessed November 6, 2023.Google Scholar
Figure 0

Table 1. Definitions of Health Equity Terminologya

Figure 1

Figure 1. Actions for individuals, institutions, and public health organizations to mitigate impacts of health inequities.